China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...

Inovio Pharmaceuticals has laid off staff and prioritized programs to focus on its lead rare disease candidate, which is ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Immutep and the Australian biotech’s investors have been caught off guard by the unexpected failure of its LAG-3 candidate in a phase 3 study. | Immutep and the Australian biotech’s investors have ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...

“Strategic transformations are a common and often successful approach in biotechnology,” Rami Levin, who took over as CEO of ...

This is a developing story. Please check back for updates. | After a tumultuous tenure marked by recent clashes with the ...

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

Insulet has begun recalling specific lots of its Omnipod 5 insulin pumps in the U.S. | The diabetes tech company said it is aware of 18 cases of serious complications related to the under-delivery of ...

BD has inked a technological partnership with automation provider Sinteco, aimed at pharmacy robotics. | The goal is to ...

According to a report from Bloomberg, the pro-Iran group Handala has publicly taken credit for the incident on social media, in response to the U.S. and Israeli strikes on the country, with claims of ...

T-cell engager (TCE) specialist Candid Therapeutics has entered into a reverse merger agreement with Rallybio that will allow ...